Updated Question and Answer Document Regarding Nitrosamines Impurities for Market Authorization Holders of Human Pharmaceutical Products

Posted Date: 23-June-2020

Updated REP Guidance Document Published

Posted By:  Linitha Ganesh

Please login to view this content.